Fatema Tabak

Dr. Fatema Tabak

Nanjing Medical University

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

18 September 2019 in Preprints.org
Verified
Preprint
Open access
PDF file
Fatema TabakFatema Tabak
Fatema Tabak
HWHui-Shan Wang
Hui-Shan Wang
QLQuanpeng Li
Quanpeng Li
XGXianxiu Ge
Xianxiu Ge
FWFei Wang
Fei Wang
LMLin Miao
Lin Miao
Endoscopic retrograde cholangiopancreatography (ERCP) is a routinely used therapeutic procedure for the biliary and pancreatic diseases. Population aging may increase the typical indications of ERCP and come with more complexity and difficulties, especially in cannulation. This study aimed to evaluate the incidence, causes, and management of difficult biliary cannulation during ERCP in super-aged patients and the role of difficult cannulation as a risk factor for adverse events. A total of 614 patients, underwent ERCP, were prospectively studied as a cohort and divided into two groups based on their age. There were 146 patients aged 80 years or older in group A and 468 patients aged less than 80 years in group B. The primary outcome measures were the difficulty grade of papilla cannulation, clinical outcomes, and ERCP-related complications in the two groups. The adverse events were analyzed using logistic regression for patient age, co-morbidities, indications, and cannulation difficulty grade variables. There was no difference in the incidence of difficult cannulation between the two groups (32.9% vs. 34.4%, p=0.765) though, as expected, super-aged Group A had a higher prevalence of periampullary diverticulum (29.5% vs. 16.7%, p=0.001). The technical cannulation success rate was (96.6% vs. 96.8%, p= 0.54). All used cannulation techniques in the elderly group were efficient and safe. Logistic regression showed that age ≥80 was not associated with increased adverse events; however, difficult cannulation (adjusted odds ratio [AOR]=3.478; 95% confidence interval [CI]=1.877, 6.442; p<0.001) and CCI ≥2 (AOR=1.824; 95% CI=0.993, 3.349; p=0.045) were more likely to have adverse events. Age ≤65 (AOR=3.460; 95% CI=1.511, 7.922; p=0.003), female gender (AOR=2.362; 95% CI=1.089, 5.124; p=0.030), difficult cannulation (AOR=4.527; 95% CI=2.078, 9.860; p<0.001), and patients with cholangitis (AOR=3.261; 95% CI=1.204, 8.832; p=0.020) were strongly associated with increasing Post-ERCP Pancreatitis (PEP). Advanced age has not proved to be a risk factor of difficult cannulation, and secondary cannulation techniques can be safely and efficaciously utilized for this group. CCI ≥2 and difficult cannulation are associated with increased overall adverse events rate while age ≥80 factor is not.

9 January 2025 in PeerJ
Verified
Journal Article
Open access
PDF file
MGMing Gao
Ming Gao
QLQing Liu
Qing Liu
LZLingyu Zhang
Lingyu Zhang
Fatema TabakFatema Tabak
Fatema Tabak
YHYifei Hua
Yifei Hua
YLYu Liu
Yu Liu
Purpose: In this study, we aimed to study the role of extracellular proteins as biomarkers associated with newly diagnosed Type 1 diabetes (NT1D) diagnosis and prognosis. Patients and Methods: We retrieved and analyzed the GSE55098 microarray dataset from the Gene Expression Omnibus (GEO) database. Using R software, we screened out the extracellular protein-differentially expressed genes (EP-DEGs) through several protein-related databases. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were applied to describe the role and function of these EP-DEGs. We used the STRING database to construct the interaction of proteins, Cytoscape software to visualize the protein-protein interaction (PPI) networks, and its plugin CytoHubba to identify the crucial genes between PPI networks. Finally, we used the comparative toxicogenomics database (CTD) to evaluate the connection between NT1D with the potential crucial genes and we validated our conclusions with another dataset (GSE33440) and some clinical samples. Results: We identified 422 DEGs and 122 EP-DEGs from a dataset that includes (12) NT1D patients compared with (10) healthy people. Protein digestion and absorption, toll-like receptor signaling, and T cell receptor signaling were the most meaningful pathways defined by KEGG enrichment analyses. We recognized nine important extracellular genes: GZMB, CCL4, TNF, MMP9, CCL5, IFNG, CXCL1, GNLY, and LCN2. CTD analyses showed that LCN2, IFNG, and TNF had higher levels in NT1D and hypoglycemia; while TNF, IFNG and MMP9 increased in hyperglycemia. Further verification showed that LCN2, MMP9, TNF and IFNG were elevated in NT1D patients. Conclusion: The nine identified key extracellular genes, particularly LCN2, IFNG, TNF, and MMP9, may be potential diagnostic biomarkers for NT1D. Our findings provide new insights into the molecular mechanisms and novel therapeutic targets of NT1D.

17 January 2020 in Preprints.org
Verified
Preprint
Open access
PDF file
Fatema TabakFatema Tabak
Fatema Tabak
GJGuozhong Ji
Guozhong Ji
LMLin Miao
Lin Miao
Aim: This study aimed to investigate the association between periampullary diverticulum (PAD) and difficult biliary cannulation, as well as to evaluate the impact of different types of PAD on the cannulation success rate and adverse events. Methods: A total of 636 patients who underwent endoscopic retrograde cholangiopancreatography (ERCP) during the study period were prospectively studied and divided into two groups based on the presence or absence of PAD. In group A, 126 patients had PAD compared with 510 patients in group B without PAD. The primary outcome measurements were ERCP procedures time, selective cannulation techniques, and cannulation difficulty in addition to cannulation success rate and ERCP-related adverse events. The difficult cannulation was analyzed using logistic regression considering age, co-morbidities, the presence of PAD types, and indications as independent factors. Results: The average cohort age was 65.30±16.67 years, and 52.7% were male. Significant higher rates of choledocholithiasis, cholangitis, and biliary pancreatitis were reported in the group of PAD (p0.05). The cannulation time was significantly longer in the presence of PAD (5.1 min, vs. 4.09 min, p<0.05). There was no significant difference in the rate of overall adverse events and post ERCP pancreatic PEP. Conclusion: The presence of PAD did not affect the duration or success of the ERCP procedure. Furthermore, it was associated with longer cannulation time and increase in the cannulation difficulty, especially with PAD type 1.

12 March 2020 in medRxiv
Verified
Preprint
Open access
PDF file
Fatema TabakFatema Tabak
Fatema Tabak
GJGuozhong Ji
Guozhong Ji
LMLin Miao
Lin Miao
Background/Aims: Transpancreatic sphincterotomy (TPS) can be an alternative approach of biliary access in difficult cannulation cases. We aimed to prospectively evaluate the efficacy and safety of TPS compared to needle-knife precut (NKP), considering the late consequences of both techniques. Methods: A total of 122 enrolled patients have been divided into three groups based on the applied secondary cannulation techniques. Selective cannulation success, ERCP procedure findings, and immediate adverse events were compared between groups. We investigated the long-term outcomes during six-month after the procedure. Results: Successful selective cannulation was achieved in 92.9% with TPS similarly to other groups. The mean procedure time was shorter in the TPS group without significant difference. Using TPS did not affect the rate of post-ERCP pancreatitis (PEP) with less frequent post-ERCP bleeding and perforation after TPS compared to NKP, without significant difference. Patients who received TPS, NKP, or both had no symptoms related to papillary stenosis or chronic pancreatitis during the follow-up period. Conclusions: Using TPS was useful to achieve success cannulation in difficult cases with an acceptable PEP rate. Furthermore, it was associated with reducing bleeding and perforation rates comparing with NKP and no differences related to the long term consequences within the follow-up period.

14 April 2023 in Endoscopy
Verified
Journal Article
Closed access
Fatema TabakFatema Tabak
Fatema Tabak
SAEED ASSANISAEED ASSANI
SAEED ASSANI
LMLin Miao
Lin Miao
Aims Although ERCP-related hyperamylasemia has a minor implication in clinical practice, post-ERCP pancreatitis (PEP) is considered a serious ERCP-related adverse event.We aimed to compare the incidence and risk factors of PEP and asymptomatic hyperamylasemia. Methods In this retrospective study, a total of 618 patients who underwent ERCP with a native papilla were divided according to the occurrence of PEP and hyperamylasemia. The primary outcomes were selective cannulation time, cannulation methods, ERCP procedure duration, and findings. Using logistic regression, we investigate the possible risk factors of PEP and hyperamylasemia considering age, gender, difficult cannulation, and using precut techniques. Results The incidence of PEP was 5.1% (n=32), while asymptomatic hyperamylasemia was reported in 9.7% (n=60). The significantly lower median Age was reported in the PEP group (p=0.004), in addition to a greater percentage of females but without significant difference. The PEP group was associated with significantly longer cannulation time (p<0.001) and a higher incidence of difficult cannulation (p=0.001), but the cannulation success rate did not differ among groups. Using transpancreatic sphincterotomy (TPS) was significantly more common in the in-hyperamylasemia group. Four risk factors for pancreatitis were identified: difficult cannulation (AOR=4.516), cholangitis (AOR=3.224), Age (AOR=2.766), and female gender (AOR=2.240) while two risk factors for hyperamylasemia; using TPS technique (AOR=2.3) and difficult cannulation (AOR=1.621). Conclusions Difficult cannulation was identified as the main risk factor for both PEP and hyperamylasemia while using TPS as difficult cannulation technique just affected serum amylase elevation ([Fig. 1]). Article published online: 14 April 2023 © 2023. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany